Shaping of an effective immune microenvironment to and by cancer cells Etienne BechtJeremy GocWolf-Herman Fridman Review 12 August 2014 Pages: 991 - 997
A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor Christian KrugManuel WiesingerNiels Schaft Original Article 18 June 2014 Pages: 999 - 1008
Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice Sungjune KimRupal RamakrishnanDmitry I. Gabrilovich Original Article 19 June 2014 Pages: 1009 - 1021
Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation Brenda De KeersmaeckerKarel FostierRik Schots Original Article 20 June 2014 Pages: 1023 - 1036
Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival—a substudy of the MIMOSA trial Alexia BuzzonettiMarco FossatiAlessandra Battaglia Original Article 21 June 2014 Pages: 1037 - 1045
Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals Bianca AltvaterSareetha KailayangiriClaudia Rossig Original Article 28 June 2014 Pages: 1047 - 1060
A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma Isabel PoschkeTanja LövgrenRolf Kiessling Original Article 04 July 2014 Pages: 1061 - 1071
Extracellular adenosine metabolism in immune cells in melanoma Viktor UmanskyIvan ShevchenkoJochen Utikal Focussed Research Review 23 April 2014 Pages: 1073 - 1080
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care? Inge Marie SvaneEls M. Verdegaal Focussed Research Review 07 August 2014 Pages: 1081 - 1091
New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia Marion SubkleweChristiane GeigerIris Bigalke Focussed Research Review 04 September 2014 Pages: 1093 - 1103
The Thirteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-13), October 2–4, 2013, Amsterdam, The Netherlands: the current standing of anti-tumor immunotherapeutic approaches Sara M. MeliefValeria V. ViscontiSaskia J. A. M. Santegoets Meeting Report 12 March 2014 Pages: 1105 - 1112
Erratum to: Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine Yinin HuGina R. PetroniCraig L. Slingluff Jr. Erratum 26 August 2014 Pages: 1113 - 1113